OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of an AXL kinase inhibitor in triple‐negative breast cancer by structure‐based virtual screening and bioactivity test
Pei Li, Yuzhen Niu, Shuyan Li, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 2, pp. 222-232
Closed Access | Times Cited: 7
Pei Li, Yuzhen Niu, Shuyan Li, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 2, pp. 222-232
Closed Access | Times Cited: 7
Showing 7 citing articles:
Computational study on the mechanism of small molecules inhibiting NLRP3 with ensemble docking and molecular dynamic simulations
P. Qin, Yuzhen Niu, Jizheng Duan, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
P. Qin, Yuzhen Niu, Jizheng Duan, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer
Rumeysa Özyurt, Bülent Özpolat
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 7, pp. 818-832
Closed Access | Times Cited: 12
Rumeysa Özyurt, Bülent Özpolat
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 7, pp. 818-832
Closed Access | Times Cited: 12
The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer
Kaiyang Xue, Jiawei Li, Ruijie Huang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Kaiyang Xue, Jiawei Li, Ruijie Huang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Recurrent neural network (RNN) model accelerates the development of antibacterial metronidazole derivatives
Nannan Chen, Lijuan Yang, Na Ding, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22893-22901
Open Access | Times Cited: 6
Nannan Chen, Lijuan Yang, Na Ding, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22893-22901
Open Access | Times Cited: 6
DISCOVERY OF DONEPEZIL-LIKE COMPOUNDS AS POTENTIAL ACETYLCHOLINESTERASE INHIBITORS DETERMINED BY PHARMACOPHORE MAPPING-BASED VIRTUAL SCREENING AND MOLECULAR DOCKING
Ferah Cömert Önder
SDÜ Tıp Fakültesi Dergisi (2023) Vol. 30, Iss. 2, pp. 143-153
Open Access | Times Cited: 3
Ferah Cömert Önder
SDÜ Tıp Fakültesi Dergisi (2023) Vol. 30, Iss. 2, pp. 143-153
Open Access | Times Cited: 3
Identification of Novel AXL Kinase Inhibitors Using Ligand-Based Pharmacophore Screening and Molecular Dynamics Simulations
Lavanya Nagamalla, J. V. Shanmukha Kumar, Mohammed Rafi Shaik, et al.
Crystals (2022) Vol. 12, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 4
Lavanya Nagamalla, J. V. Shanmukha Kumar, Mohammed Rafi Shaik, et al.
Crystals (2022) Vol. 12, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 4
Discovery of an EP300 Inhibitor using Structure-based Virtual Screening and Bioactivity Evaluation
Dabo Pan, Yaxuan Huang, Dewen Jiang, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 25, pp. 1985-1994
Open Access
Dabo Pan, Yaxuan Huang, Dewen Jiang, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 25, pp. 1985-1994
Open Access
Structure-based virtual screening of FDA-approved drugs to discover potential inhibitors of phosphoinositide kinase, PIKfyve
Bhagyashri N. Wadje, Tejaswi Somarowthu, Shikha Thakur, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access
Bhagyashri N. Wadje, Tejaswi Somarowthu, Shikha Thakur, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access
